Total Payments
$1,613
2023 Payments
$48.00
Companies
8
Transactions
24
Medicare Patients
24,098
Medicare Billing
$1.8M
Payment Breakdown by Category
Travel$824.52 (51.1%)
Food & Beverage$788.79 (48.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $824.52 | 4 | 51.1% |
| Food and Beverage | $788.79 | 20 | 48.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $1,336 | 14 | $0 (2017) |
| Stemline Therapeutics Inc. | $87.96 | 2 | $0 (2020) |
| Myriad Genetic Laboratories, Inc. | $50.52 | 2 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $40.98 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $27.58 | 2 | $0 (2020) |
| Lundbeck LLC | $25.27 | 1 | $0 (2023) |
| Tris Pharma Inc | $22.77 | 1 | $0 (2022) |
| United Therapeutics Corporation | $22.73 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $48.00 | 2 | Lundbeck LLC ($25.27) |
| 2022 | $22.77 | 1 | Tris Pharma Inc ($22.77) |
| 2021 | $50.52 | 2 | Myriad Genetic Laboratories, Inc. ($50.52) |
| 2020 | $115.54 | 4 | Stemline Therapeutics Inc. ($87.96) |
| 2017 | $1,376 | 15 | Merck Sharp & Dohme Corporation ($1,336) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.27 | General |
| Category: PSYCHIATRY | ||||||
| 05/04/2023 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: PAH | ||||||
| 11/24/2022 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: ADHD | ||||||
| 03/21/2021 | Myriad Genetic Laboratories, Inc. | myPath (Device) | Food and Beverage | Cash or cash equivalent | $23.15 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 01/26/2021 | Myriad Genetic Laboratories, Inc. | myPath (Device) | Food and Beverage | Cash or cash equivalent | $27.37 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 12/02/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: PSYCHIATRY | ||||||
| 10/20/2020 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: ONCOLOGY | ||||||
| 03/03/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: PSYCHIATRY | ||||||
| 01/27/2020 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $65.10 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Food and Beverage | In-kind items and services | $40.98 | General |
| Category: Central Nervous System | ||||||
| 02/07/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Travel and Lodging | Cash or cash equivalent | $45.54 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Food and Beverage | Cash or cash equivalent | $18.12 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Food and Beverage | Cash or cash equivalent | $3.84 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Food and Beverage | In-kind items and services | $39.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Travel and Lodging | In-kind items and services | $177.84 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Food and Beverage | In-kind items and services | $49.07 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Food and Beverage | In-kind items and services | $39.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Travel and Lodging | In-kind items and services | $423.30 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Travel and Lodging | In-kind items and services | $177.84 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2017 | Merck Sharp & Dohme Corporation | MK-8189 (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 7,220 | 10,159 | $2.6M | $533,191 |
| 2022 | 9 | 6,510 | 9,516 | $2.3M | $494,203 |
| 2021 | 9 | 5,208 | 8,023 | $1.9M | $420,049 |
| 2020 | 10 | 5,160 | 7,663 | $1.9M | $397,724 |
Total Patients
24,098
Total Services
35,361
Medicare Billing
$1.8M
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 5,285 | 7,505 | $2.0M | $356,615 | 17.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 799 | 918 | $228,752 | $65,767 | 28.8% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 422 | 828 | $206,250 | $50,811 | 24.6% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 401 | 488 | $113,079 | $37,906 | 33.5% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Office | 2023 | 27 | 108 | $17,280 | $9,113 | 52.7% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 205 | 215 | $31,139 | $5,836 | 18.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 41 | 57 | $9,576 | $3,306 | 34.5% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Office | 2023 | 25 | 25 | $5,125 | $2,753 | 53.7% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Office | 2023 | 15 | 15 | $3,720 | $1,086 | 29.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 4,848 | 7,148 | $1.7M | $329,603 | 18.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 771 | 899 | $224,750 | $65,706 | 29.2% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2022 | 263 | 627 | $156,750 | $40,338 | 25.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 345 | 426 | $99,525 | $34,056 | 34.2% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Office | 2022 | 36 | 144 | $23,040 | $12,359 | 53.6% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2022 | 150 | 169 | $23,532 | $4,457 | 18.9% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Office | 2022 | 35 | 35 | $7,038 | $3,610 | 51.3% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 40 | 46 | $7,728 | $2,613 | 33.8% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Office | 2022 | 22 | 22 | $5,456 | $1,459 | 26.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 3,842 | 5,883 | $1.4M | $268,591 | 18.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2021 | 590 | 707 | $176,750 | $53,760 | 30.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2021 | 116 | 563 | $141,750 | $37,854 | 26.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2021 | 342 | 393 | $91,873 | $31,497 | 34.3% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Office | 2021 | 44 | 180 | $28,800 | $14,488 | 50.3% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2021 | 168 | 184 | $25,479 | $4,869 | 19.1% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Office | 2021 | 42 | 43 | $8,815 | $4,535 | 51.4% |
About Nasir Zaidi, MD, PHD
Nasir Zaidi, MD, PHD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851317465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nasir Zaidi, MD, PHD has received a total of $1,613 in payments from pharmaceutical and medical device companies, with $48.00 received in 2023. These payments were reported across 24 transactions from 8 companies. The most common payment nature is "Travel and Lodging" ($824.52).
As a Medicare-enrolled provider, Zaidi has provided services to 24,098 Medicare beneficiaries, totaling 35,361 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Other Specialties Anatomic Pathology & Clinical Pathology, Anatomic Pathology & Clinical Pathology
- Location Memphis, TN
- Active Since 07/15/2006
- Last Updated 11/22/2024
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1851317465
Products in Payments
- MK-8189 (Drug) $1,336
- ELZONRIS (Drug) $87.96
- myPath (Device) $50.52
- SD809-TD (Drug) $40.98
- ABILIFY MAINTENA (Drug) $27.58
- REXULTI (Drug) $25.27
- Dyanavel XR (Drug) $22.77
- ORENITRAM (Drug) $22.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Memphis
Charles Handorf, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $187,215
Anatomic Pathology & Clinical Pathology $187,215
Robert Bradley, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $5,642
Anatomic Pathology & Clinical Pathology $5,642
Holly Pierce, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $3,171
Anatomic Pathology & Clinical Pathology $3,171
Dr. Charles Beavers, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $2,060
Anatomic Pathology & Clinical Pathology $2,060
Richard Roberts, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $509.71
Anatomic Pathology & Clinical Pathology $509.71
Dr. Frank Osborn, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $495.05
Anatomic Pathology & Clinical Pathology $495.05